The European Life Sciences Web Portal
This is a free web portal for the life sciences in Europe and Israel... » read more
- Curetis Expands Commercial Team, Appoints Head of Sales EMEA (2016-02-03)
Curetis N.V. (the "Company" and, together with Curetis AG, "Curetis"), a developer of next-level molecular diagnostic solutions, today announced the expansion of its commercial and general administrative team. As of February 1, 2016, Willem Haagmans has joined t...
- Labiotech.eu Raises €-6-digit Seed Financing Round – cg pd (2016-02-03)
The Berlin-based startup Labiotech.eu announces having raised a 6-figure seed-round from lead investor WestTech Ventures as well as 5 European business angels (Sven Fund, Bertrand Landel, Simon Bungers, Michel Lurquin and Adveris). Labiotech.eu was founded by Jo...
- Pierre Fabre Group Unveils Pierre Fabre Fund for Innovation (2016-02-03)
> Pierre Fabre will accompany biotech companies, startups and research laboratories specialized in oncology, onco-dermatology or dermatology, primarily in France and Europe > This program aims at speeding up the development process of new products currently at a...
- Medicxi Ventures Launches with €210m Closing of MV1 Fund (2016-02-03)
> Medicxi Ventures comprises all of the existing life sciences team, portfolio company investments and life sciences funds of Index Ventures > GSK and Johnson & Johnson Innovation expand their commitment to the asset-centric approach > Index Ventures technolo...
- Adaptimmune and GSK Expand Immunotherapy Collaboration (2016-02-02)
> Agreement accelerates development of Adaptimmune’s lead T-cell therapy targeting NY-ESO-1 toward pivotal trials > Creates opportunity for up to eight combination studies Adaptimmune Therapeutics plc (Nasdaq: ADAP), a leader in the use of T- cell receptor ...
- Cell Therapy Catapult Is Now Cell and Gene Therapy Catapult (2016-02-02)
The Cell Therapy Catapult, the UK organisation dedicated to the growth of the UK cell and gene therapy industry by bridging the gap between scientific research and commercialisation, today announces the official change of its name to the Cell and Gene Therapy Catap...
- Xeltis Appoints Paul van Hagen as CFO (2016-02-02)
Xeltis has bolstered its executive team with the appointment of Paul van Hagen as Chief Financial Officer. Van Hagen joins Xeltis with over 20 years of experience as a financial professional, working for private and public healthcare companies. In his previous role...
- Mission Therapeutics Raises £60m to Advance DUB Inhibitors (2016-02-02)
Woodford Patient Capital Trust joins existing syndicate supporting transition to clinical development MISSION Therapeutics, a drug discovery and development company focused on selectively targeting deubiquitylating enzymes to treat cancer, neurodegenerative a...
- Qiagen Announces New Bioinformatics Agreements (2016-02-02)
FDA centers and researchers gain access to QIAGEN’s enhanced solutions for applications including microbial and microbiome analysis QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced new partnerships to enhance the profile and expand the...
- Abbott to Acquire Alere for $5.8b, Expanding in PoC Testing (2016-02-01)
ABBOTT GAINS LEADERSHIP IN THE $5.5 BILLION POINT OF CARE SEGMENT, BROADENS DIAGNOSTICS FOOTPRINT AND ENHANCES ACCESS TO FAST-GROWING DIAGNOSTICS CHANNELS - Transaction expected to be immediately accretive to Abbott's ongoing earnings per share upon close - A...
Life-Sciences-Europe.com is your doorway to the European life sciences!
[LSE] provides free, up-to-date and structured access to
in Europe and Israel.
Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSE] is 100% Made in Germany!Start here with the latest News!
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to firstname.lastname@example.org and simply fill the subject line with the word »LSE newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]